Millipore Sigma Vibrant Logo

239765 InSolution™ Cycloheximide - CAS 66-81-9 - Calbiochem

InSolution™ Cycloheximide, CAS 66-81-9, is a 100 mg/ml, sterile-filtered solution of Cycloheximide (Cat. No. 239763) in DMSO. An antifungal antibiotic that inhibits protein synthesis in eukaryotes.

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.
Primary Target: hFKBP12
View Products on Sigmaaldrich.com
239765
  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
—
Bitte erfragen
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information

      Key Spec Table

      CAS #Empirical Formula
      66-81-9C₁₅H₂₃NO₄
      Description
      Catalogue Number239765
      Brand Family Calbiochem®
      References
      ReferencesChristner, C., et al. 1999. J. Med. Chem. 42, 3615.
      Lu, Q. and Mellgreen,R.L. 1996. Arch. Biochem. Biophys. 334, 175.
      Chow, S.C., et al. 1995. Exp. Cell Res. 216, 149.
      Waring, P. 1990. J. Biol. Chem. 265, 14476.
      Obrig, T.G., et al. 1971. J. Biol. Chem. 246, 174.
      Pestka, S. 1971. Annu. Rev. Microbiol. 25, 487.
      Product Information
      CAS number66-81-9
      FormLiquid
      FormulationA 100 mg/ml solution of Cycloheximide (Cat. No. 239763) in DMSO (sterile-filtered).
      Hill FormulaC₁₅H₂₃NO₄
      Chemical formulaC₁₅H₂₃NO₄
      Quality LevelMQ100
      Applications
      ApplicationInSolution™ Cycloheximide, CAS 66-81-9, is a 100 mg/ml, sterile-filtered solution of Cycloheximide (Cat. No. 239763) in DMSO. An antifungal antibiotic that inhibits protein synthesis in eukaryotes.
      Biological Information
      Primary TargethFKBP12
      Primary Target K<sub>i</sub>3.4 µM
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSMA4375000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Highly Toxic & Carcinogenic / Teratogenic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial use, aliquot and refrigerate (4°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      239765 0

      Documentation

      InSolution™ Cycloheximide - CAS 66-81-9 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      InSolution™ Cycloheximide - CAS 66-81-9 - Calbiochem Analysenzertifikate

      TitelChargennummer
      239765

      Literatur

      Übersicht
      Christner, C., et al. 1999. J. Med. Chem. 42, 3615.
      Lu, Q. and Mellgreen,R.L. 1996. Arch. Biochem. Biophys. 334, 175.
      Chow, S.C., et al. 1995. Exp. Cell Res. 216, 149.
      Waring, P. 1990. J. Biol. Chem. 265, 14476.
      Obrig, T.G., et al. 1971. J. Biol. Chem. 246, 174.
      Pestka, S. 1971. Annu. Rev. Microbiol. 25, 487.

      Literaturstellen

      Titel
    • Hui Zeng, et al. (2005) Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. American Journal of Physiology Gastrointestinal and Liver Physiology in press,.
      		•
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-June-2008 RFH
      DescriptionA convenient ready-to-use form of Cycloheximide (Cat. No. 239763). An anti-fungal antibiotic that inhibits protein synthesis in eukaryotes but not in prokaryotes. Interacts directly with the translocase enzyme, interfering with the translocation step. Also inhibits cell-free protein synthesis in eukaryotes. Competitively inhibits hFKBP12 (Ki = 3.4 µM). Triggers apoptosis in HL-60 cells, T-cell hybridomas, Burkitt's lymphoma cells, and a variety of other cell types, including rodent macrophages. Induces DNA fragmentation in macrophages, but inhibits DNA cleavage in rat thymocytes treated with thapsigargin, methylprednisolone, and ionomycin. Rapidly destroyed in alkaline solutions.
      FormLiquid
      FormulationA 100 mg/ml solution of Cycloheximide (Cat. No. 239763) in DMSO (sterile-filtered).
      Intert gas (Yes/No) Packaged under inert gas
      CAS number66-81-9
      RTECSMA4375000
      Chemical formulaC₁₅H₂₃NO₄
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial use, aliquot and refrigerate (4°C).
      Toxicity Highly Toxic & Carcinogenic / Teratogenic
      ReferencesChristner, C., et al. 1999. J. Med. Chem. 42, 3615.
      Lu, Q. and Mellgreen,R.L. 1996. Arch. Biochem. Biophys. 334, 175.
      Chow, S.C., et al. 1995. Exp. Cell Res. 216, 149.
      Waring, P. 1990. J. Biol. Chem. 265, 14476.
      Obrig, T.G., et al. 1971. J. Biol. Chem. 246, 174.
      Pestka, S. 1971. Annu. Rev. Microbiol. 25, 487.
      Citation
    • Hui Zeng, et al. (2005) Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. American Journal of Physiology Gastrointestinal and Liver Physiology in press,.
      		•